[HTML][HTML] Miktoarm star polymers: Branched architectures in drug delivery

V Lotocki, A Kakkar - Pharmaceutics, 2020 - mdpi.com
Delivering active pharmaceutical agents to disease sites using soft polymeric nanoparticles
continues to be a topical area of research. It is becoming increasingly evident that the …

Miktoarm Star Polymers: Branched Architectures in Drug Delivery.

V Lotocki, A Kakkar - Pharmaceutics, 2020 - europepmc.org
Delivering active pharmaceutical agents to disease sites using soft polymeric nanoparticles
continues to be a topical area of research. It is becoming increasingly evident that the …

Miktoarm Star Polymers: Branched Architectures in Drug Delivery.

V Lotocki, A Kakkar - Pharmaceutics, 2020 - search.ebscohost.com
Delivering active pharmaceutical agents to disease sites using soft polymeric nanoparticles
continues to be a topical area of research. It is becoming increasingly evident that the …

Miktoarm Star Polymers: Branched Architectures in Drug Delivery

V Lotocki, A Kakkar - Pharmaceutics, 2020 - pubmed.ncbi.nlm.nih.gov
Delivering active pharmaceutical agents to disease sites using soft polymeric nanoparticles
continues to be a topical area of research. It is becoming increasingly evident that the …

[HTML][HTML] Miktoarm Star Polymers: Branched Architectures in Drug Delivery

V Lotocki, A Kakkar - Pharmaceutics, 2020 - ncbi.nlm.nih.gov
Delivering active pharmaceutical agents to disease sites using soft polymeric nanoparticles
continues to be a topical area of research. It is becoming increasingly evident that the …

[PDF][PDF] Miktoarm Star Polymers: Branched Architectures in Drug Delivery

V Lotocki, A Kakkar - pdfs.semanticscholar.org
Delivering active pharmaceutical agents to disease sites using soft polymeric nanoparticles
continues to be a topical area of research. It is becoming increasingly evident that the …

Miktoarm Star Polymers: Branched Architectures in Drug Delivery

V Lotocki, A Kakkar - Pharmaceutics, 2020 - search.proquest.com
Delivering active pharmaceutical agents to disease sites using soft polymeric nanoparticles
continues to be a topical area of research. It is becoming increasingly evident that the …